HHS, DOD invest to expand U.S. COVID-19 test production
The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity. HHS and DOD awarded to Hologic, Inc. $119 million to expand the supplier’s production capacity for COVID-19 tests made at facilities in Wisconsin, Maine and California.
The funds are expected to increase Hologic’s production capacity to 13 million tests per month by January 2022.
The agencies also announced a $12.7 million contract with InBios International, Inc., to expand production of two rapid point-of-care SARS-CoV-2 tests. The funds will enable InBios to reach a production capacity of 400,000 units per week by May 2021.
Related News Articles
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…